Cargando…
HOXA Amplification Defines a Genetically Distinct Subset of Angiosarcomas
Angiosarcoma is a rare, devastating malignancy with few curative options for disseminated disease. We analyzed a recently published genomic data set of 48 angiosarcomas and noticed recurrent amplifications of HOXA-cluster genes in 33% of patients. HOXA genes are master regulators of embryonic vascul...
Autores principales: | Xie, Hongbo M., Bernt, Kathrin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406048/ https://www.ncbi.nlm.nih.gov/pubmed/36009018 http://dx.doi.org/10.3390/biom12081124 |
Ejemplares similares
-
Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina)
por: Burel, Agnès, et al.
Publicado: (2006) -
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
por: Courjal, F., et al.
Publicado: (1996) -
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay
por: Raghav, Kanwal, et al.
Publicado: (2020) -
MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015) -
Primary Angiosarcoma of the Skin Presenting as Mild Erythema
por: Moon, Sun Young, et al.
Publicado: (2017)